Articles Tagged With: Influenza
-
Influenza and Pertussis Vaccines for Pregnant Women: Are We Doing Enough to Encourage Vaccination?
In this cross-sectional analysis, pregnant women disproportionately accounted for 24-34% of influenza-associated hospitalizations among women aged 15 to 44 years, and infants younger than 2 months of age comprised the highest proportion of pertussis deaths. The reasons why pregnant women did not elect recommended immunizations included not believing they were effective, not knowing they should receive Tdap every pregnancy, and being concerned that the vaccines would harm the fetus.
-
AMA Calls for Flu Vaccines for Most Americans
The group says pregnant women are an especially vulnerable population.
-
2019 Community Acquired Pneumonia in Adults Guideline — Not Much New Under the Sun
The 2019 guideline differs from the 2007 version to only a limited extent.
-
Child Deaths Spur Flu Vaccination Urgency
Public health officials are underscoring the tragedy of severe influenza infections and deaths in children, adding a palpable sense of urgency for immunization in an era when some parents are suspicious of vaccine efficacy and safety.
-
CDC: Flu Vaccination Can Keep You out of the Hospital, Morgue
Given the nation’s antivaccine movement and the annual safety myths and efficacy quibbles about the seasonal influenza vaccine, public health officials are keeping it simple this year: A flu shot can keep you out of the hospital and the morgue.
-
ID Groups Demand Border Patrol Give Detainees Flu Shots
The U.S. Customs and Border Protection’s (CBP) decision to not vaccinate migrants in detention facilities against flu and other infections is being slammed by leading clinicians and public health officials. -
Vancomycin for MRSA Pneumonia Following Influenza in Children
Coinfection with methicillin-resistant Staphylococcus aureus (MRSA) in children with influenza is associated with high fatality. Data support the addition of a second anti-MRSA antibiotic to vancomycin in severely ill children.
-
Baloxavir Marboxil (Xofluza)
Baloxavir marboxil is a novel, oral, antiviral agent approved by the Food and Drug Administration (FDA) on Oct. 24, 2018, for the treatment of acute uncomplicated influenza in patients 12 years of age and older.
-
Influenza Cases Rising: What Clinicians Need to Know
The burden of influenza is significant. So far in the current 2018-2019 season, about 7 million Americans have been affected, with half of those people seeing a physician. Between 69,000 and 84,000 people have been hospitalized for flu-related illness.
-
The Influenza Virus: Winter Is Coming
Influenza is an acute respiratory illness responsible for significant seasonal epidemics each year. Despite commonly being a self-limited illness, the virus causes significant morbidity and mortality. During the winter months, emergency physicians should maintain a high suspicion for influenza in patients presenting with an acute febrile respiratory illness.